Mimedx (MDXG) Total Non-Current Liabilities (2010 - 2026)
Mimedx's (MDXG) quarterly Total Non-Current Liabilities came in at $54.2 million in Q2 2026, down 19.7% year-over-year from $67.5 million in Q2 2025, and down 10.62% quarter-over-quarter from $60.6 million in Q1 2026.
Analysis
Mimedx (MDXG) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Mimedx has disclosed Total Non-Current Liabilities across 17 years of filings, most recently posting $54.2 million for Q2 2026.
- In Q2 2026, Total Non-Current Liabilities fell 19.7% year-over-year to $54.2 million; the TTM figure through Jun 2026 stood at $54.2 million (down 19.7% YoY), while the FY2025 annual figure was $80.7 million, up 27.29% from the prior year.
- Total Non-Current Liabilities came in at $54.2 million for Q2 2026 at Mimedx, down from $60.6 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $94.3 million in Q3 2022 to a low of $54.2 million in Q2 2026.
- Average Total Non-Current Liabilities over 5 years is $75.9 million, with a median of $77.6 million recorded in 2025.
- Year-over-year, Total Non-Current Liabilities sank 37.55% in 2024 and advanced 27.29% in 2025.
- Over 5 years, Total Non-Current Liabilities stood at $92.2 million in 2022, then grew by 2.12% to $94.1 million in 2023, then sank by 32.6% to $63.4 million in 2024, then rose by 27.29% to $80.7 million in 2025, then sank by 32.86% to $54.2 million in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $54.2 million in Q2 2026, $60.6 million in Q1 2026, and $80.7 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Mimedx | 667.30 Mn | 531.46 Mn | 44.38 Mn | 54.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 54.20 Mn |
| Mar 31, 2026 | 60.64 Mn |
| Dec 31, 2025 | 80.73 Mn |
| Sep 30, 2025 | 74.52 Mn |
| Jun 30, 2025 | 67.50 Mn |
| Mar 31, 2025 | 60.15 Mn |
| Dec 31, 2024 | 63.43 Mn |
| Sep 30, 2024 | 59.96 Mn |
| Jun 30, 2024 | 58.26 Mn |
| Mar 31, 2024 | 60.67 Mn |
| Dec 31, 2023 | 94.11 Mn |
| Sep 30, 2023 | 92.59 Mn |
| Jun 30, 2023 | 93.30 Mn |
| Mar 31, 2023 | 89.58 Mn |
| Dec 31, 2022 | 92.15 Mn |
| Sep 30, 2022 | 94.33 Mn |
| Jun 30, 2022 | 85.49 Mn |
| Mar 31, 2022 | 84.83 Mn |
| Dec 31, 2021 | 90.48 Mn |
| Sep 30, 2021 | 89.76 Mn |